List of Excipients in API human insulin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing human insulin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| A-S Medication Solutions | NOVOLIN | human insulin | 50090-0403 | GLYCERIN | |
| A-S Medication Solutions | NOVOLIN | human insulin | 50090-0403 | HYDROCHLORIC ACID | |
| A-S Medication Solutions | NOVOLIN | human insulin | 50090-0403 | METACRESOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for human insulin
Excipient focus: GLYCERIN
human insulin drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1833 |
| Novo Nordisk | human insulin | 0169-1834 |
| Novo Nordisk | human insulin | 0169-1837 |
| >Company | >Ingredient | >NDC |
human insulin drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
human insulin drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1833 |
| Novo Nordisk | human insulin | 0169-1834 |
| Novo Nordisk | human insulin | 0169-1837 |
| >Company | >Ingredient | >NDC |
human insulin drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METACRESOL
human insulin drug variants containing METACRESOL
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1833 |
| Novo Nordisk | human insulin | 0169-1834 |
| Novo Nordisk | human insulin | 0169-1837 |
| >Company | >Ingredient | >NDC |
human insulin drug variants not containing METACRESOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PHENOL
human insulin drug variants containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1834 |
| Novo Nordisk | human insulin | 0169-1837 |
| A-S Medication Solutions | human insulin | 50090-0403 |
| >Company | >Ingredient | >NDC |
human insulin drug variants not containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1833 |
| A-S Medication Solutions | human insulin | 50090-0497 |
| TYA Pharmaceuticals | human insulin | 64725-1833 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROTAMINE SULFATE
human insulin drug variants containing PROTAMINE SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1834 |
| Novo Nordisk | human insulin | 0169-1837 |
| A-S Medication Solutions | human insulin | 50090-0403 |
| >Company | >Ingredient | >NDC |
human insulin drug variants not containing PROTAMINE SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1833 |
| A-S Medication Solutions | human insulin | 50090-0497 |
| TYA Pharmaceuticals | human insulin | 64725-1833 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
human insulin drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1833 |
| Novo Nordisk | human insulin | 0169-1834 |
| Novo Nordisk | human insulin | 0169-1837 |
| >Company | >Ingredient | >NDC |
human insulin drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC
human insulin drug variants containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1834 |
| Novo Nordisk | human insulin | 0169-1837 |
| A-S Medication Solutions | human insulin | 50090-0403 |
| >Company | >Ingredient | >NDC |
human insulin drug variants not containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1833 |
| A-S Medication Solutions | human insulin | 50090-0497 |
| Physicians Total Care Inc | human insulin | 54868-3474 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
human insulin drug variants containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | human insulin | 54868-3474 |
| TYA Pharmaceuticals | human insulin | 64725-1834 |
| TYA Pharmaceuticals | human insulin | 64725-1837 |
| >Company | >Ingredient | >NDC |
human insulin drug variants not containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1833 |
| Novo Nordisk | human insulin | 0169-1834 |
| Novo Nordisk | human insulin | 0169-1837 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
human insulin drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1833 |
| Novo Nordisk | human insulin | 0169-1834 |
| Novo Nordisk | human insulin | 0169-1837 |
| >Company | >Ingredient | >NDC |
human insulin drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC
human insulin drug variants containing ZINC
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1833 |
| Novo Nordisk | human insulin | 0169-1834 |
| Novo Nordisk | human insulin | 0169-1837 |
| >Company | >Ingredient | >NDC |
human insulin drug variants not containing ZINC
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | human insulin | 54868-3474 |
| TYA Pharmaceuticals | human insulin | 64725-1833 |
| TYA Pharmaceuticals | human insulin | 64725-1834 |
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC CHLORIDE
human insulin drug variants containing ZINC CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | human insulin | 54868-3474 |
| TYA Pharmaceuticals | human insulin | 64725-1833 |
| TYA Pharmaceuticals | human insulin | 64725-1834 |
| >Company | >Ingredient | >NDC |
human insulin drug variants not containing ZINC CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | human insulin | 0169-1833 |
| Novo Nordisk | human insulin | 0169-1834 |
| Novo Nordisk | human insulin | 0169-1837 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch